NYSE:LYV Long Term Investor Notice: Investigation over Possible Wrongdoing by Live Nation Entertainment, Inc.
Certain directors of Live Nation Entertainment, Inc. are under investigation over potential breaches of fiduciary duties.Zai Lab Limited (NASDAQ:ZLAB) Investor Alert: Investigation over Potential Wrongdoing
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Zai Lab Limited.NYSE:ANF Investor Notice: Investigation over Possible Securities Laws Violations by Abercrombie & Fitch Co.
Abercrombie & Fitch Co. is under investigation over potential securities laws violations in connection with certain statements.NASDAQ:SPWR Shareholder Notice: Lawsuit Alleges Misleading Statements by SunPower Corporation
An investor, who purchased shares of SunPower Corporation (NASDAQ:SPWR), filed a lawsuit over alleged violations of Federal Securities Laws by SunPower Corporation.NASDAQ:FUTU Long Term Investor Notice: Investigation over Potential Wrongdoing at Futu Holdings Limited
Certain directors of Futu Holdings Limited are under investigation over potential breaches of fiduciary duties.NASDAQ:SEDG Investor Notice: Lawsuit Alleges Securities Laws Violations by SolarEdge Technologies, Inc.
An investor, who purchased shares of SolarEdge Technologies, Inc. (NASDAQ:SEDG), filed a lawsuit over alleged violations of Federal Securities Laws by SolarEdge Technologies, Inc.Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Shareholder Notice: Lawsuit Alleges Violations of Securities Laws
An investor, who purchased NASDAQ:BCLI shares, filed a lawsuit against Brainstorm Cell Therapeutics Inc over alleged violations of Federal Securities Laws.NASDAQ:DCGO Investor Notice: Lawsuit Alleges Misleading Statements by DocGo Inc.
The Shareholders Foundation announced that an investor, who purchased shares of DocGo Inc. (NASDAQ:DCGO), filed a lawsuit over alleged violations of Federal Securities Laws by DocGo Inc.NASDAQ:APLS Long Term Investor Notice: Investigation of Potential Wrongdoing at Apellis Pharmaceuticals, Inc.
Certain directors of Apellis Pharmaceuticals, Inc. are under investigation on behalf of current long-term investors in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) concerning potential breaches of fiduciary duties.NYSE:LUMN Investor Alert: Deadline on November 14, 2023 in Lawsuit Against Lumen Technologies, Inc. Coming Up
The Shareholders Foundation announced that a deadline is coming up on November 14, 2023 in the lawsuit filed for certain investors of Lumen Technologies, Inc. (NYSE:LUMN).